vcvibes

Third Rock Ventures, LLC.

Third Rock Ventures VI, L.P.

Late investment period

Late investment period: first sale May 2022, per Form D (fund age approximates vintage)

Visit their website
Vintage
2022
Fund size
$1105.34M to $1111.09M (Form D and SEC adviser filing)
Stages
Seed
Sectors
Biotech
Regions
US

01 · Thesis

Third Rock Ventures is a biotechnology venture capital firm that builds companies from scientific discovery, starting at the seed stage. It focuses on medicines that address unmet medical need and aims to bring breakthrough products to patients.Inferred from the firm's website

02 · Initial check

$11.05M to $18.52M (estimated from fund size)

Estimated from Form D and SEC adviser filing

03 · Who to approach

Named on this fund's Form D

  • Neil Exter, Manager of the GPLLC.
  • David Kaufman, Manager of the GPLLC.
  • Abbie Celniker, Manager of the GPLLC.
  • Kevin Gillis, Manager of the GPLLC.
  • Robert Tepper, Manager of the GPLLC.
  • Reid Huber, Manager of the GPLLC.
  • Jeffrey Tong, Manager of the GPLLC.
  • Cary Pfeffer, Manager of the GPLLC.

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

  • Firm-wideThird Rock builds biotechnology companies that discover and develop products that make a difference for the patients it serves.

    we are a leading biotechnology venture capital firm
    https://www.thirdrockventures.com/approach

06 · Sources

  1. https://www.thirdrockventures.com/approach
  2. https://www.sec.gov/Archives/edgar/data/1931056/000101297522000263/

Last verified: Oct 28, 2026